Cargando…

Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus

BACKGROUND: X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by Bruton’s tyrosine kinase (BTK) mutation. Patients are susceptible to severe enterovirus infections. The underlying mechanism remains unknown. BTK is involved in toll-like receptors pathway, which initiates antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Luk, Anderson Dik Wai, Ni, Ke, Wu, Yuet, Lam, Kwok-Tai, Chan, Koon-Wing, Lee, Pamela P., Tu, Wenwei, Mao, Huawei, Lau, Yu Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095995/
https://www.ncbi.nlm.nih.gov/pubmed/30147693
http://dx.doi.org/10.3389/fimmu.2018.01826
_version_ 1783348027692417024
author Luk, Anderson Dik Wai
Ni, Ke
Wu, Yuet
Lam, Kwok-Tai
Chan, Koon-Wing
Lee, Pamela P.
Tu, Wenwei
Mao, Huawei
Lau, Yu Lung
author_facet Luk, Anderson Dik Wai
Ni, Ke
Wu, Yuet
Lam, Kwok-Tai
Chan, Koon-Wing
Lee, Pamela P.
Tu, Wenwei
Mao, Huawei
Lau, Yu Lung
author_sort Luk, Anderson Dik Wai
collection PubMed
description BACKGROUND: X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by Bruton’s tyrosine kinase (BTK) mutation. Patients are susceptible to severe enterovirus infections. The underlying mechanism remains unknown. BTK is involved in toll-like receptors pathway, which initiates antiviral responses including interferon (IFN) productions. OBJECTIVE: To demonstrate type I and III IFN productions in dendritic cells of XLA patients is decreased in response to oral poliovirus vaccine (OPV) but not H1N1 virus. METHODS: Monocyte-derived dendritic cells (MoDCs) were derived from nine XLA patients aged 22–32 years old and 23 buffy coats from Hong Kong Red Cross blood donors. LFM-A13 was used to inhibit BTK. OPV Sabin type 1 and H1N1 influenza virus were used to stimulate MoDCs with RPMI as mock stimulation. The antiviral cytokine productions and phenotypic maturation of MoDCs were determined 24 h post-stimulation. OPV RNA was determined at 0, 6, 12, and 24 h post-stimulation. RESULTS: Upon OPV stimulation, IFN-α2, IFN-β, and IFN-λ1 productions in MoDCs from XLA patients and BTK-inhibited MoDCs of healthy controls were significantly lower than that from healthy controls. Whereas upon H1N1 stimulation, the IFN-α2, IFN-β, and IFN-λ1 productions were similar in MoDCs from XLA patients, BTK-inhibited MoDCs of healthy controls and healthy controls. The mean fluorescent intensities (MFI) of CD83, CD86, and MHC-II in MoDCs from XLA patients in response to OPV was similar to that in response to mock stimulation, while the MFI of CD83, CD86, and MHC-II were significantly higher in response to H1N1 stimulation than that in response to mock stimulation. Whereas, the MFI of CD83, CD86, and MHC-II in MoDCs of healthy controls were significantly higher in response to both OPV and H1N1 stimulation compared to that in response to mock stimulation. CONCLUSION: Production of type I and III IFN in response to OPV was deficient in MoDCs from XLA patients, but was normal in response to H1N1 due to deficient BTK function. Moreover, phenotypic maturation of MoDCs from XLA patients was impaired in response to OPV but not to H1N1. These selective impairments may account for the unique susceptibility of XLA patients toward severe enterovirus infections.
format Online
Article
Text
id pubmed-6095995
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60959952018-08-24 Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus Luk, Anderson Dik Wai Ni, Ke Wu, Yuet Lam, Kwok-Tai Chan, Koon-Wing Lee, Pamela P. Tu, Wenwei Mao, Huawei Lau, Yu Lung Front Immunol Immunology BACKGROUND: X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by Bruton’s tyrosine kinase (BTK) mutation. Patients are susceptible to severe enterovirus infections. The underlying mechanism remains unknown. BTK is involved in toll-like receptors pathway, which initiates antiviral responses including interferon (IFN) productions. OBJECTIVE: To demonstrate type I and III IFN productions in dendritic cells of XLA patients is decreased in response to oral poliovirus vaccine (OPV) but not H1N1 virus. METHODS: Monocyte-derived dendritic cells (MoDCs) were derived from nine XLA patients aged 22–32 years old and 23 buffy coats from Hong Kong Red Cross blood donors. LFM-A13 was used to inhibit BTK. OPV Sabin type 1 and H1N1 influenza virus were used to stimulate MoDCs with RPMI as mock stimulation. The antiviral cytokine productions and phenotypic maturation of MoDCs were determined 24 h post-stimulation. OPV RNA was determined at 0, 6, 12, and 24 h post-stimulation. RESULTS: Upon OPV stimulation, IFN-α2, IFN-β, and IFN-λ1 productions in MoDCs from XLA patients and BTK-inhibited MoDCs of healthy controls were significantly lower than that from healthy controls. Whereas upon H1N1 stimulation, the IFN-α2, IFN-β, and IFN-λ1 productions were similar in MoDCs from XLA patients, BTK-inhibited MoDCs of healthy controls and healthy controls. The mean fluorescent intensities (MFI) of CD83, CD86, and MHC-II in MoDCs from XLA patients in response to OPV was similar to that in response to mock stimulation, while the MFI of CD83, CD86, and MHC-II were significantly higher in response to H1N1 stimulation than that in response to mock stimulation. Whereas, the MFI of CD83, CD86, and MHC-II in MoDCs of healthy controls were significantly higher in response to both OPV and H1N1 stimulation compared to that in response to mock stimulation. CONCLUSION: Production of type I and III IFN in response to OPV was deficient in MoDCs from XLA patients, but was normal in response to H1N1 due to deficient BTK function. Moreover, phenotypic maturation of MoDCs from XLA patients was impaired in response to OPV but not to H1N1. These selective impairments may account for the unique susceptibility of XLA patients toward severe enterovirus infections. Frontiers Media S.A. 2018-08-10 /pmc/articles/PMC6095995/ /pubmed/30147693 http://dx.doi.org/10.3389/fimmu.2018.01826 Text en Copyright © 2018 Luk, Ni, Wu, Lam, Chan, Lee, Tu, Mao and Lau. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Luk, Anderson Dik Wai
Ni, Ke
Wu, Yuet
Lam, Kwok-Tai
Chan, Koon-Wing
Lee, Pamela P.
Tu, Wenwei
Mao, Huawei
Lau, Yu Lung
Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title_full Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title_fullStr Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title_full_unstemmed Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title_short Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus
title_sort type i and iii interferon productions are impaired in x-linked agammaglobulinemia patients toward poliovirus but not influenza virus
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095995/
https://www.ncbi.nlm.nih.gov/pubmed/30147693
http://dx.doi.org/10.3389/fimmu.2018.01826
work_keys_str_mv AT lukandersondikwai typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT nike typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT wuyuet typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT lamkwoktai typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT chankoonwing typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT leepamelap typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT tuwenwei typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT maohuawei typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus
AT lauyulung typeiandiiiinterferonproductionsareimpairedinxlinkedagammaglobulinemiapatientstowardpoliovirusbutnotinfluenzavirus